A
RXRX icon

AlphaQuest’s Recursion Pharmaceuticals RXRX Stock Holding History

AlphaQuest’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,879
Closed -$28.1K – 1684
2025
Q4 		$28.1K Hold
6,879
– – ﹤0.01% 2053
2025
Q3 		$33.6K Hold
6,879
– – ﹤0.01% 2018
2025
Q2 		$34.8K Hold
6,879
– – ﹤0.01% 1692
2025
Q1 		$36.4K Buy
+6,879
New +$50.1K ﹤0.01% 1594
2024
Q4 		– Sell
-9,645
Closed -$63.6K – 1972
2024
Q3 		$63.6K Sell
9,645
-14,574
-60% -$104K 0.01% 1363
2024
Q2 		$182K Buy
24,219
+8,351
+53% +$72.8K 0.02% 777
2024
Q1 		$158K Sell
15,868
-3,800
-19% -$42.3K 0.03% 722
2023
Q4 		$194K Buy
+19,668
New +$140K 0.04% 626

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AlphaQuest's RXRX Position: Q1 2026 in Review

AlphaQuest sold out of Recursion Pharmaceuticals (RXRX) in Q1 2026, closing a stake of 6,879 shares — an estimated $28.1K sold.

AlphaQuest first reported a position in RXRX in Q4 2023 and held it in 8 quarters. The position peaked at $194K in Q4 2023. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • AlphaQuest reported no remaining Recursion Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 6,879 Recursion Pharmaceuticals shares in Q1 2026, an estimated $28.1K.
  • AlphaQuest first reported a position in Recursion Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Recursion Pharmaceuticals position peaked at $194K in Q4 2023.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.